BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26529297)

  • 21. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.
    Ray B; Lahiri DK
    Curr Opin Pharmacol; 2009 Aug; 9(4):434-44. PubMed ID: 19656726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial treatment of tart cherry extract and essential fatty acids reduces cognitive impairments and inflammation in the mu-p75 saporin-induced mouse model of Alzheimer's disease.
    Matchynski JJ; Lowrance SA; Pappas C; Rossignol J; Puckett N; Sandstrom M; Dunbar GL
    J Med Food; 2013 Apr; 16(4):288-95. PubMed ID: 23566055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic protective effects of phytochemicals in Alzheimer's disease.
    Davinelli S; Sapere N; Zella D; Bracale R; Intrieri M; Scapagnini G
    Oxid Med Cell Longev; 2012; 2012():386527. PubMed ID: 22690271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease.
    Bendheim PE; Poeggeler B; Neria E; Ziv V; Pappolla MA; Chain DG
    J Mol Neurosci; 2002; 19(1-2):213-7. PubMed ID: 12212784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.
    Braidy N; Jugder BE; Poljak A; Jayasena T; Mansour H; Nabavi SM; Sachdev P; Grant R
    Curr Top Med Chem; 2016; 16(17):1951-60. PubMed ID: 26845555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.
    El Gaamouch F; Liu K; Lin HY; Wu C; Wang J
    Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
    Ayaz M; Mosa OF; Nawaz A; Hamdoon AAE; Elkhalifa MEM; Sadiq A; Ullah F; Ahmed A; Kabra A; Khan H; Murthy HCA
    Phytomedicine; 2024 Feb; 124():155272. PubMed ID: 38181530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease.
    Calfio C; Gonzalez A; Singh SK; Rojo LE; Maccioni RB
    J Alzheimers Dis; 2020; 77(1):33-51. PubMed ID: 32651325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
    Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
    Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.
    Kou X; Chen N
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28837083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
    Kim J; Lee HJ; Lee KW
    J Neurochem; 2010 Mar; 112(6):1415-30. PubMed ID: 20050972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoprenoids and Alzheimer's disease: a complex relationship.
    Cole SL; Vassar R
    Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease.
    da Rocha MD; Viegas FP; Campos HC; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):251-70. PubMed ID: 20874701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.
    Caraci F; Spampinato S; Sortino MA; Bosco P; Battaglia G; Bruno V; Drago F; Nicoletti F; Copani A
    Cell Tissue Res; 2012 Jan; 347(1):291-301. PubMed ID: 21879289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.